Partnering for Progress
Your osteosarcoma science fund with our support and infrastructure
By establishing an osteosarcoma science fund at The Osteosarcoma Institute, you can select the expertly-vetted research study or clinical trial that we have committed to fund and to which you would like to direct your fund. OSI’s funding partnerships give osteosarcoma families a seat at the table next to expert physicians and research scientists who can interpret and guide them through the complex process of research funding. This opportunity allows families impacted by osteosarcoma to tangibly track a specific research project aiming for progress against the disease. Your name, or the name of your loved one, will be associated with the research project of your choice once the target goal has been met!
To learn more or to create your fund, please contact our Director of Development, Vanessa (Peterson) Montemayor, at giving@osinst.org.
Featured Funds
Families leading the way in advancing osteosarcoma research through extraordinary commitment and impact.
TeamIzzy Foundation Research Fund
The TeamIzzy Foundation Research Fund at OSI was established in honor of Izzy Martin, who raised nearly $300,000 for osteosarcoma research before her passing in 2022. Today, her family continues to carry forward Izzy’s wish that one day no child will have to endure this disease.
$860,000+ directed to research
as of April 2026
Research supported
OSI-funded studies
Seth Pollack, Northwestern University
Defying Osteosarcoma TeamLab, Break Through Cancer
Miles of Hope Fund
Ingrid and David Hartz established the Miles of Hope Fund at OSI in 2022 in honor of their son, Miles, who passed away from osteosarcoma on June 25, 2023, at age 17 after a five-year battle with the disease. Through their fund, the Hartz family is helping advance promising osteosarcoma research in Miles’ memory.
$730,000+ directed to research
as of April 2026
Research supported
Richard Gorlick, MD Anderson Cancer Center
Poul Sorensen, University of British Columbia
Isidro Cortes Ciriano, EMBL
Partnering for Progress Families
Camden’s Quest 2 Cure Fund
Camden’s Quest 2 Cure Fund at OSI was established in honor of Camden Bailey, who passed away in 2025 after a courageous battle with osteosarcoma. Camden’s family continues his legacy by advancing research through the Camden Bailey Cancer Foundation which Camden established before his passing.
$25,000 pledged for research
as of April 2026
Research supported
To be directed toward osteosarcoma research through OSI
Charlotte Murdoff Research Fund
The Charlotte Murdoff Research Fund was established by Alli and Sherrick Murdoff in loving memory of their daughter, Charlotte, who passed away on September 22, 2021, after a courageous three-year battle with osteosarcoma. Through their fund, they are honoring Charlotte’s legacy while helping accelerate the research needed to improve outcomes and bring hope to osteosarcoma patients and families.
$25,000 pledged for research
as of July 2026
Research supported
To be directed toward osteosarcoma research through OSI
Lizzy’s Osteosarcoma Science Fund
Established in 2020 in honor of Lizzy Wampler, Lizzy’s Osteosarcoma Science Fund continues to support research in her memory. Through their fund, Lizzy’s family is helping advance both OSI’s broader research efforts and promising investigator-led studies.
$175,000+ directed to research
as of April 2026
Research supported
OSI-funded studies
Brian Crompton, Dana-Farber Cancer Institute
Team Lydia Osteosarcoma Science Fund
Jessica and Steve Alwan created the Team Lydia Osteosarcoma Science Fund at OSI in 2022 to advance osteosarcoma research in honor of their daughter, Lydia, who was diagnosed in 2019. Now more than three years cancer-free, Lydia’s journey continues to inspire support for promising new research.
$245,000+ directed to research
as of April 2026
Research supported
Poul Sorensen, University of British Columbia
Noelle Strong Foundation
The Noelle Strong Foundation OSI honors Noelle Franklin and is dedicated to bringing hope, strength, and action to families facing osteosarcoma. Through their work, the foundation supports research, raises awareness, and provides critical support to families navigating this disease.
$25,000 pledged for research
as of April 2026
Research supported
To be directed toward osteosarcoma research through OSI
Shumiestrong Osteosarcoma Science Fund
Elizabeth and Jim Shumadine established the Shumiestrong Osteosarcoma Science Fund at OSI in 2024 in honor of their son, Sam, who passed away from osteosarcoma in January 2024. Through their fund, the Shumadine family is supporting promising new research to help improve outcomes for osteosarcoma patients.
$322,000+ directed to research
as of April 2026
Research supported
Brian Crompton, Dana-Farber Cancer Institute
Robin Parihar, Baylor College of Medicine
Defying Osteosarcoma TeamLab, Break Through Cancer
Ryan Roberts, Nationwide Children’s Hospital
The Scott Shockley Foundation
Founded in memory of Scott Shockley, who passed away from osteosarcoma in July 2013, the Scott Shockley Foundation continues to honor his legacy through support of osteosarcoma research. Through their fund, the Shockley family is helping advance promising new treatment approaches for patients facing this disease.
$51,000+ directed to research
as of April 2026
Research supported
Jason Yustein, Emory University
Robin Parihar, Baylor College of Medicine
Sid and Karen Sijbrandij
In 2024, Sid and Karen Sijbrandij established their family fund at OSI to support a promising osteosarcoma research study led by Dr. Seth Pollack.
$250,000 directed to research
as of April 2026
Research supported
Defying Osteosarcoma TeamLab, Break Through Cancer
Fabulous Faith’s Foundation
Founded in memory of 10-year-old Faith Rose Lautzenheiser, who passed away after a 10-month battle with osteosarcoma, Fabulous Faith’s Foundation generously supported osteosarcoma research in her honor. The foundation helped support three osteosarcoma research projects, including one named for Faith, the inspiration behind its work.
$75,000 directed to research
legacy fund
Research supported
Katherine Janeway, Dana-Farber Cancer Institute
Alejandro Sweet-Cordero, UCSF
Robin Parihar, Baylor College of Medicine